Raphaël Leblanc

1.1k citations
22 papers · 836 · h-index 14

Impact in

    • MicroRNA in disease regulation
  • Oncology top 10%
    • Inflammatory Biomarkers in Disease Prognosis
    • Cancer Cells and Metastasis

Papers in

    • Sphingolipid Metabolism and Signaling 10
    • Ubiquitin and proteasome pathways 4
    • Extracellular vesicles in disease 4
    • Protein Degradation and Inhibitors 2
    • Hippo pathway signaling and YAP/TAZ 4
    • Endoplasmic Reticulum Stress and Disease 2
    • Cellular transport and secretion 2

Raphaël Leblanc

21 papers receiving 827 citations

Peers

Raphaël Leblanc
Comparison fields: 5 of 70
  • Cancer Research 156
  • Oncology 268
  • Cell Biology 164
  • Internal Medicine 26
  • Molecular Biology 534
Replace Joanna W. Ho with:
Joanna W. Ho Hong Kong
Behrouz Zand United States
David Cervi United States
Thijs J. Hagenbeek Netherlands
Kaori Koga Japan
Sujatha Jagadeeswaran United States
Ana M. Gil‐Bernabé United Kingdom
Marina Cinelli Italy
Russell Ross United States
Christopher M. Raskett United States
Raphaël Leblanc relative to Joanna W. Ho Hong Kong Joanna W. Ho's profile →
Citations per field
00.5×4.9×
Joanna W. Ho · 1×
Citations per year

Countries citing papers authored by Raphaël Leblanc

Since Specialization
Citations

This map shows the geographic impact of Raphaël Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Leblanc more than expected).

Fields of papers citing papers by Raphaël Leblanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Leblanc. The network helps show where Raphaël Leblanc may publish in the future.

Co-authors

The 25 scholars most cited alongside Raphaël Leblanc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphaël Leblanc Line = papers co-authored together Raphaël Leblanc links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016177
2 2014137
3 201485
4 202079
5 201555
6 201843
7 201443
8 202040
9 201830
10 201228
11 201925
12 201425
13 201617
14 202115
15 202313
16 202110
17 20236
18 20234
19 20212
20 20141

About Raphaël Leblanc

Raphaël Leblanc is a scholar working on Molecular Biology, Cell Biology, Pulmonary and Respiratory Medicine, Cancer Research and Physiology, having authored 22 papers that have together received 836 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (10 papers), Ubiquitin and proteasome pathways (4 papers), Extracellular vesicles in disease (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Cell Adhesion Molecules Research (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Protein Degradation and Inhibitors (2 papers) and Cellular transport and secretion (2 papers). The work is most often cited by research in Cancer Research (156 citations), Oncology (268 citations), Cell Biology (164 citations), Internal Medicine (26 citations) and Molecular Biology (534 citations). Raphaël Leblanc has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Olivier Peyruchaud, Debashish Sahay, Marion David, Johnny Ribeiro, Philippe Clézardin, Pascale Zimmermann, Sue-Chin Lee, Duane D. Miller, Renukadevi Patil and Derek D. Norman. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Oncotarget, Journal of Medicinal Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact